Evidence map›Paper›PMID 40406751›Full record

ArticleCureus2025

Accumulation of N-Isopropyl-p(123I)iodoamphetamine on Single-Photon Emission Computed Tomography Between Immunosuppressed and Non-immunosuppressed Patients With Primary Central Nervous System Lymphoma.

Yuki Sakaeyama, Yutaka Fuchinoue, Chie Matsuura, Masaaki Nemoto, Ryo Matsuzaki, Shuhei Kubota, Mitsuyoshi Abe, Sayaka Terazono, Nobuo Sugo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Delayed Uptake onClinical case reports · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuki SakaeyamaDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.
Yutaka FuchinoueDepartment of Neurosurgery (Sakura), Faculty of Medicine, Toho University, Chiba, JPN.
Chie MatsuuraDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.
Masaaki NemotoDepartment of Neurosurgery (Sakura), Faculty of Medicine, Toho University, Chiba, JPN.
Ryo MatsuzakiDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.
Shuhei KubotaDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.
Mitsuyoshi AbeDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.
Sayaka TerazonoDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.
Nobuo SugoDepartment of Neurosurgery (Omori), Faculty of Medicine, Toho University, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Primary central nervous system lymphoma (PCNSL) is a rare type of malignant tumor. Due to the rapidly progressive nature of PCNSL, early diagnosis is important, and imaging plays a key role in this process. In particular, N-isopropyl-p(123I)iodoamphetamine (

Indexed as

immunosuppressedn-isopropyl-p-[123i]-iodoamphetamine single-photon emission computed tomographynon-immunosuppressedprimary central nervous system lymphoma (pcnsl)tumor immune microenvironment

Identifiers

PMID40406751
PMCPMC12096338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.